Ruggie Capital Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Ruggie Capital Group’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,637	Closed	-$1.44M	–	52
2019 Q3	$1.44M	Buy	11,637 +11,165	+2,365%	+$1.49M	1.91%	17
2019 Q2	$64K	Sell	472 -9,947	-95%	-$1.37M	0.11%	51
2019 Q1	$1.57M	Sell	10,419 -19,583	-65%	-$2.82M	1.85%	16
2018 Q4	$3.73M	Buy	30,002 +21,801	+266%	+$2.98M	1.67%	15
2018 Q3	$1.3M	Sell	8,201 -818	-9%	-$124K	0.87%	26
2018 Q2	$1.26M	Buy	9,019 +2,218	+33%	+$305K	0.64%	31
2018 Q1	$901K	Sell	6,801 -2,519	-27%	-$344K	0.49%	38
2017 Q4	$1.08M	Buy	+9,320	New	+$1.15M	0.7%	26

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ruggie Capital Group's FBT Position: Q4 2019 in Review

Ruggie Capital Group sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2019, closing a stake of 11,637 shares — an estimated $1.44M sold.

Ruggie Capital Group first reported a position in FBT in Q4 2017 and held it in 8 quarters. The position peaked at $3.73M in Q4 2018. 210 funds tracked by Wall St. Rank hold FBT as of Q4 2019.

Ruggie Capital Group reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2019 after selling out during the quarter.
Ruggie Capital Group sold 11,637 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2019, an estimated $1.44M.
Ruggie Capital Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and held it in 8 quarters.
Ruggie Capital Group's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.73M in Q4 2018.
210 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2019.

Based on Ruggie Capital Group's 13F filing for Q4 2019, filed 14 Feb 2020.